Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Expert Review of Anticancer Therapy|April 20, 2010
Patient-based strategy for systemic treatment of metastatic renal cell carcinomaHartmut Kirchner, Dirk Strumberg, Amit Bahl, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2012
IL-2 upregulates CD86 expression on human CD4(+) and CD8(+) T cellsAnanta Paine, Hartmut Kirchner, Stephan Immenschuh, et al.Haematologica|December 7, 2007
A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapyMarie von Lilienfeld-Toal, Corinna Hahn-Ast, Hartmut Kirchner, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 10, 2002
Technique and results of hyperthermic (41 degrees C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasisCarsten Schröder, Stefan Fisher, Anne Christin Pieck, et al.Journal of Cancer Research and Clinical Oncology|December 17, 2009
The role of surgery in clinical management of patients with metastatic papillary renal cell carcinomaThomas Steiner, Hartmut Kirchner, Michael Siebels, et al.Annals of Hematology|December 13, 2012
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemiaFelicitas Thol, Claudia Winschel, Ann-Kathrin Sonntag, et al.Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.Annals of Hematology|March 24, 2017
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemiaAnna Both, Jürgen Krauter, Frederik Damm, et al.Pageof 2